HE2000: Began Phase II study

Hollis-Eden Pharmaceuticals Inc. (HEPH), San Diego,

Read the full 63 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE